California Public Employees Retirement System lessened its holdings in Bruker Co. (NASDAQ:BRKR – Free Report) by 5.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 199,723 shares of the medical research company’s stock after selling 11,620 shares during the quarter. California Public Employees Retirement System owned 0.14% of Bruker worth $14,764,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in BRKR. Tower Research Capital LLC TRC grew its position in Bruker by 31.8% in the first quarter. Tower Research Capital LLC TRC now owns 5,455 shares of the medical research company’s stock valued at $430,000 after acquiring an additional 1,316 shares during the period. Signaturefd LLC grew its holdings in shares of Bruker by 19.2% in the 1st quarter. Signaturefd LLC now owns 889 shares of the medical research company’s stock worth $70,000 after purchasing an additional 143 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Bruker by 747.0% during the 2nd quarter. Pacer Advisors Inc. now owns 20,759 shares of the medical research company’s stock worth $1,535,000 after purchasing an additional 18,308 shares in the last quarter. Treasurer of the State of North Carolina lifted its holdings in Bruker by 0.7% during the 1st quarter. Treasurer of the State of North Carolina now owns 46,875 shares of the medical research company’s stock valued at $3,696,000 after purchasing an additional 340 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Bruker by 10.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,063 shares of the medical research company’s stock valued at $2,055,000 after buying an additional 2,470 shares in the last quarter. Institutional investors and hedge funds own 79.78% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on BRKR shares. JPMorgan Chase & Co. cut their target price on shares of Bruker from $70.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, October 17th. StockNews.com began coverage on Bruker in a research report on Thursday, October 5th. They issued a “buy” rating for the company.
Bruker Price Performance
BRKR opened at $61.28 on Tuesday. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.89 and a quick ratio of 1.04. The stock has a market capitalization of $8.48 billion, a P/E ratio of 28.24, a price-to-earnings-growth ratio of 2.23 and a beta of 1.14. The company’s 50 day simple moving average is $60.97 and its 200-day simple moving average is $67.36. Bruker Co. has a one year low of $53.79 and a one year high of $84.84.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies.
- Five stocks we like better than Bruker
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- The most upgraded stocks in November have two things in common
- What Are Dividend Achievers? An Introduction
- Monday.com rocked earnings like it’s the weekend
- How to Calculate Inflation Rate
- Plan to own one retailer? Make it this one
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.